Differences in coronary microvascular lesions in coronary heart disease and hypertension: an autopsy study of elderly

Xiao-ying Li1, Rui Li, Wen Yu

  • 1Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing 100853, China. lixy@mx.cei.gov.cn

Chinese Medical Journal
|February 21, 2004
PubMed

Insights

Coronary microvascular lesions (CML) are more severe in elderly patients with essential hypertension (EHT) and coronary heart disease (CHD). These microvascular changes significantly impact myocardial damage and coronary flow reserve in these patient groups.

Area of Science:

  • Cardiovascular Pathology
  • Geriatric Medicine
  • Microcirculation Research

Background:

  • Hypertension leads to microvascular lesions in target organs, preceding arterial arteriosclerosis.
  • Coronary microvascular lesion (CML) is a critical factor in target organ damage.
  • Understanding CML differences in elderly patients with essential hypertension (EHT), coronary heart disease (CHD), or both is crucial.

Purpose of the Study:

  • To investigate and compare the characteristics of CML in autopsies of elderly patients.
  • To analyze CML differences in patients with EHT, CHD, or combined EHT and CHD.
  • To correlate CML with left ventricular wall thickness (LVWT) across different cardiovascular conditions.

Main Methods:

  • Retrospective autopsy study of 3195 cases, focusing on 246 patients over 60 with EHT, CHD, or both, plus 26 controls.
  • Histological examination (H&E, EVG, CD31) of cardiac arterioles and capillaries.
  • Quantification of CML using arteriole density (AD), arteriole wall-to-lumen ratio (RWL), and capillary density (CD) via image analysis.

Main Results:

  • In EHT, increasing LVWT correlated with increased AD and RWL, and decreased CD.
  • EHT with CHD showed similar but more severe changes than EHT alone.
  • CHD alone exhibited increased AD but no significant changes in RWL or CD with increasing LVWT.

Conclusions:

  • Coronary microvascular lesion (CML) severity is significantly greater in elderly patients with combined EHT and CHD.
  • Distinct patterns in arteriole wall-to-lumen ratio (RWL) and capillary density (CD) differentiate EHT from CHD.
  • CML is a primary contributor to reduced coronary flow reserve and myocardial damage in EHT and EHT with CHD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...